OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
Marcos Castanheira Alegria is R&D director at Hypera Pharma.
This article introduces the requirements for a biosimilar license in Brazil and addresses questions about their quality, safety, and efficacy.